The achievement of the first sales milestone already in the second year of commercialization is a testament of the commercial capability of our partner AKP in this important market. The strong sales ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

While forcing federal employees back into the office five days a week sounds like it would increase productivity, research ...

Peterborough’s essential clubbing brand, UNDER, has announced over 50 acts to appear at its May bank holiday weekender at its unique home beneath the Nene Parkway Flyover in the city.

An outstanding entry of 1342 prime cattle on offer at Clogher Mart on Saturday 1st February sold to an excellent demand as prices keep on rising for a lot of top quality stock presented.

CELEBRITY Hunted star Chloe Veitch has revealed her abusive relationship with an ex, saying strangers would stop her in the street and beg her to leave him. Chloe, 25, who competed on the Channel ...

J.P. Morgan Payments, the payments arm of banking giant JPMorgan Chase & Co., is blazing its own path with two new payment terminals, both proprietary to the payment service. Announced Monday, the J.P ...

The Westin St. Francis Hotel in Union Square will once again be host for one of the biggest conventions in the city--the J.P. Morgan Healthcare Conference. The conference includes global industry ...

The efforts are aimed at keeping the roughy 20,000 health care executives and investors safe as well as highlighting downtown San Francisco's recovery progress. San Francisco and its hotel ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US initial public offering as soon as this year, according to people ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...